Delta Tissue — Execution
Funds United Kingdom tissue profiling research for improved diagnostics and disease state understanding.
Delta Tissue is a $55 million Wellcome Leap program developing platforms to profile tissue states and predict disease progression transitions — what the program describes as a "tissue time machine" capable of predicting future disease progression with sufficient precision to enable present-day intervention. Program Director Jason Swedlow, PhD — a chromosome segregation expert and co-founder of the…
Platform development for profiling tissue states and predicting disease progression transitions, aimed at enabling early intervention across academic, startup, and clinical settings.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Write proposalGrant Proposal Abstract and Executive Summary: Examples That Work
Learn how to write a grant proposal abstract or executive summary, what to include, how it differs from a project summary, and how to use examples without copying.
DocumentsLetter of Support for Grant Applications: Template and Examples
Learn how to write and request a letter of support for a grant, with template structure, examples, reviewer logic, and common mistakes.
More from Wellcome Leap
All grants from this funder →1kD — Execution
Wellcome Leap · United States
Funds United Kingdom infant brain development research programs focused on translational collaboration.
CARE — Execution
Wellcome Leap · United States
Supports United Kingdom efforts to understand endocrine factors in cognitive aging and dementia risk.
Dynamic Resilience — Execution
Wellcome Leap · United States
Funds healthspan-oriented research in the United Kingdom toward resilient aging and wellness strategies.
Focused Antibiotics
Wellcome Leap · United States
Funds United Kingdom and global teams redesigning antibiotic strategies while preserving gut microbiome health.
FORM
Wellcome Leap · United States
Funds United Kingdom maternal and infant microbiome research to improve long-term health outcomes.
HOPE — Execution
Wellcome Leap · United States
Supports United Kingdom human organ engineering collaborations focused on translational tissue platforms.
Similar grants
Browse the directory →
ASPIRE Reduction-to-Practice (Seed)
🇺🇸NCATS · United States
Supports translational chemistry and automation platform development through university-linked partnerships.
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research
NIH · United States
Funds research using a screening trial's biorepository — serial blood samples collected before diagnosis, with decades of matched participant data.
ARPA-H Mission Office ISOs
🇺🇸ARPA-H · United States
Supports United States mission teams with boundary-pushing health initiatives beyond existing programme limits.
NIAID Clinical Trial Implementation Cooperative Agreement
NIH · United States
Funds running an investigator-initiated, milestone-driven clinical trial that needs closer NIH oversight, including any mechanistic sub-studies.
NIAMS Clinical Trial Implementation Cooperative Agreement
NIH · United States
Funds a two-phase cooperative agreement to prepare for, then run, a clinical trial in arthritis, musculoskeletal or skin disease.
Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose
NIH · United States
Funds discovering and developing a medication or device to prevent or treat substance use disorders and overdose, in two phases.